Abiopharma

🔍 O'Donnell Daniel J. (Executive)

Company: Princeton Bancorp, Inc. (BPRN)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 91 shares of Phantom stock (Derivative)
  Date: 2026-03-30 | Code: I | equity_swap_involved: false | shares_owned_after: 91.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 61 shares of Phantom stock (Derivative)
  Date: 2026-03-30 | Code: I | equity_swap_involved: false | shares_owned_after: 152.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 1 shares of Phantom stock (Derivative)
  Date: 2026-05-28 | Code: I | equity_swap_involved: false | shares_owned_after: 153.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Acquired under the Princeton Bancorp, Inc. Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of Princeton Bancorp, Inc. common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of employment.